Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Tijs Merckaert

3 Results

2021

An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells

Tijs MerckaertOlivier ZwaenepoelKris GevaertJan Gettemans

A1 Journal Article in BIOMEDICINE & PHARMACOTHERAPY

2021

Unravelling AKT2 signalling in cancer through nanobody technology

Tijs MerckaertJan GettemansKris Gevaert

Dissertation

2021

2020

Development and characterization of protein kinase B/AKT isoform-specific nanobodies

Tijs MerckaertOlivier ZwaenepoelKris GevaertJan Gettemans

A1 Journal Article in PLOS ONE

2020